Valeant Pharmaceuticals Intl Inc VRX shares are trading higher by $1.15 at $27.05. The issue is getting a lift off the announcement that Andrew Left of Citron Research is long the issue.
Left was the one of the first to call out the issue as a short and is now trying it find from the long side.
The issue reached its lowest level since November 2010 last week when it bottomed at $23.55. It rebounded to end the week at $25.90.
The news of Left's stake has for the moment pushed the issue beyond the pair of highs from Thursday ($26.67) and Friday ($26.60), jumping into the $27 handle, with $27.15 standing as the current high.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
